| Overview of the Israeli start up pharmaceutical industry
|Nissim Darvish M.D., Ph.D.
Senior Managing Director, OrbiMed Israel
|Quality and Regulatory aspects in early phase development of pharmaceutical products
Founder, CEO and Consultant
ADRES, Advanced Regulatory Services Ltd.
|The Israeli Healthtech Industry in the Era of Precision Medicine
|Itai Kela, PhD, MBA
Senior Director, Healthcare & Biotechnology Sector Technology Division
Israel Innovation Authority
|Strategic Considerations for Manufacturing Process Development
|Oren Hershkovitz, Ph.D.
OPKO Biologics Ltd. (f.k.a. Prolor-Biotech Ltd.)
|Preclinical and Toxicological aspects in early phase development of pharmaceutical products
|Liat Hershkovitz, Ph.D
Director, Scientific and Regulatory Affairs
ADRES Advanced Regulatory Services Ltd.
|Developing your Process for future scale-up and commercial viability
CEO, Biopharmax Ltd
|Drug Development -
Points to Consider
The Regulator View
|Dr. Ofra Axelrod
Director of The Institute for Standardization and Control of Pharmaceuticals, Israeli MOH